Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Constellium Se (CSTM) Research & Development (2016 - 2025)

Historic Research & Development for Constellium Se (CSTM) over the last 14 years, with Q3 2025 value amounting to $12.0 million.

  • Constellium Se's Research & Development rose 909.09% to $12.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.0 million, marking a year-over-year increase of 10559.12%. This contributed to the annual value of $49.0 million for FY2024, which is 576.92% down from last year.
  • Latest data reveals that Constellium Se reported Research & Development of $12.0 million as of Q3 2025, which was up 909.09% from $12.0 million recorded in Q2 2025.
  • Constellium Se's Research & Development's 5-year high stood at $15.0 million during Q1 2024, with a 5-year trough of -$16.3 million in Q4 2022.
  • In the last 5 years, Constellium Se's Research & Development had a median value of -$10.8 million in 2021 and averaged -$3.5 million.
  • Its Research & Development has fluctuated over the past 5 years, first plummeted by 5855.06% in 2022, then soared by 20750.03% in 2024.
  • Over the past 5 years, Constellium Se's Research & Development (Quarter) stood at -$10.3 million in 2021, then plummeted by 58.55% to -$16.3 million in 2022, then rose by 1.13% to -$16.1 million in 2023, then surged by 161.96% to $10.0 million in 2024, then rose by 20.0% to $12.0 million in 2025.
  • Its last three reported values are $12.0 million in Q3 2025, $12.0 million for Q2 2025, and $13.0 million during Q1 2025.